Department of Surgery, Duke University Medical Center, DUMC Box 103035, Durham, NC 27710, USA.
Arch Immunol Ther Exp (Warsz). 2013 Aug;61(4):255-71. doi: 10.1007/s00005-013-0227-0. Epub 2013 Apr 7.
Aptamers are short, single-stranded oligonucleotides that are isolated through a process termed systematic evolution of ligands by exponential enrichment. With the advent of cell-based selection technology, aptamers can be selected to bind protein targets that are expressed on the cell surface. These aptamers demonstrate excellent specificity and high affinity toward their target proteins and are often internalized upon binding to their targets. This has opened up the possibility of using aptamers for cell-specific targeted drug delivery. In this review, we will discuss cell-surface protein targets, the aptamers that bind them, and their applications for targeted therapeutics.
适体是通过一种称为指数富集的配体系统进化过程分离得到的短的单链寡核苷酸。随着基于细胞的选择技术的出现,适体可以被选择来结合在细胞表面表达的蛋白质靶标。这些适体对其靶蛋白表现出优异的特异性和高亲和力,并且在与靶标结合时常常被内化。这为利用适体进行细胞特异性靶向药物递送开辟了可能性。在这篇综述中,我们将讨论细胞表面蛋白靶标、与它们结合的适体及其在靶向治疗中的应用。